- Home
- VVV vs INSP Comparison
VVV vs INSP Comparison
Compare VVV & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVV
- INSP
- Stock Information
- Founded
- VVV 1866
- INSP 2007
- Country
- VVV United States
- INSP United States
- Employees
- VVV N/A
- INSP N/A
- Industry
- VVV Major Chemicals
- INSP Medical/Dental Instruments
- Sector
- VVV Industrials
- INSP Health Care
- Exchange
- VVV Nasdaq
- INSP Nasdaq
- Market Cap
- VVV 5.4B
- INSP 5.2B
- IPO Year
- VVV 2016
- INSP 2018
- Fundamental
- Price
- VVV $42.31
- INSP $172.77
- Analyst Decision
- VVV Buy
- INSP Buy
- Analyst Count
- VVV 8
- INSP 11
- Target Price
- VVV $47.75
- INSP $226.18
- AVG Volume (30 Days)
- VVV 918.1K
- INSP 570.0K
- Earning Date
- VVV 11-19-2024
- INSP 11-04-2024
- Dividend Yield
- VVV N/A
- INSP N/A
- EPS Growth
- VVV N/A
- INSP N/A
- EPS
- VVV 1.27
- INSP 1.09
- Revenue
- VVV $1,573,500,000.00
- INSP $755,594,000.00
- Revenue This Year
- VVV $13.13
- INSP $29.96
- Revenue Next Year
- VVV $12.61
- INSP $19.42
- P/E Ratio
- VVV $27.96
- INSP $157.93
- Revenue Growth
- VVV 13.29
- INSP 32.52
- 52 Week Low
- VVV $33.86
- INSP $123.00
- 52 Week High
- VVV $48.27
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- VVV 53.25
- INSP 34.22
- Support Level
- VVV $42.47
- INSP $196.12
- Resistance Level
- VVV $43.20
- INSP $204.93
- Average True Range (ATR)
- VVV 0.82
- INSP 10.27
- MACD
- VVV 0.09
- INSP -2.67
- Stochastic Oscillator
- VVV 59.41
- INSP 5.77
About VVV Valvoline Inc.
Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.